Peter Verbrugghe

KU Leuven

Papers

1

Total Citations

38

H-Index

1

About

Peter Verbrugghe is a leading anesthesiology and perioperative medicine researcher whose work centers on regional anesthesia techniques and enhanced recovery after cardiac surgery. His most impactful contribution is the landmark 2023 randomized placebo-controlled trial on the erector spinae plane (ESP) block for robotically-assisted coronary artery bypass surgery. This study, which has garnered 38 citations, provided high-level evidence that the ESP block significantly reduces postoperative pain and opioid consumption, challenging conventional analgesic approaches in minimally invasive cardiac procedures. Verbrugghe’s research directly addresses the critical need for multimodal, opioid-sparing pain management in cardiac surgery, improving patient outcomes and recovery trajectories. His work is notable for its rigorous methodology and clinical relevance, helping to establish ESP blocks as a viable, evidence-based option in this high-risk population. By bridging the gap between regional anesthesia innovation and cardiac surgical practice, Verbrugghe has made a tangible impact on postoperative care standards, offering a safer, more effective pathway for patients undergoing robotically-assisted coronary bypass.

Research Focus

Key Achievements

1
H-Index
1
Papers
38
Total Citations
38
Avg Citations/Paper
🏆 Most Cited Paper
Erector spinae plane block for postoperative analgesia in robotically-assisted coronary artery bypass surgery: Results of a randomized placebo-controlled trial
38 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: KU Leuven

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago